期刊文献+

青海省非综合征型耳聋患者线粒体DNA12SrRNA A1555G和GJB2基因突变检测分析 被引量:1

AN EVALUATION OF mtDNA A1555G AND GJB2 MUTATIONS IN PATIENTS WITH NONSYNDROMIC SENSORINEURAL HEARING LOSS IN QINGHAI PROVINCE
下载PDF
导出
摘要 目的检测和分析青海省非综合征型耳聋患者线粒体DNA12SrRNA A1555G突变和GJB2突变流行病学特征,为耳聋基因诊断方法和筛查策略提供数据基础。方法应用聚合酶链反应对青海省261例耳聋患者的线粒体12SrRNA基因和GJB2第2外显子基因编码区进行扩增;限制性内切酶Alw26I检测线粒体DNA A1555G突变。对酶切提示A1555G突变的病例和全部GJB2基因扩增产物进行DNA测序。结果在261例患者中,16例携带A1555G突变,突变频率为6.13%,其中汉族10例(7.14%)、回族6例(7.23%),两个民族之间A1555G突变频率无显著性差异(P>0.05);25例具有GJB2已知致病突变,致病突变频率为9.58%,其中汉族20例(14.29%)、回族3例(3.61%)、土族2例(40.00%),汉族GJB2基因突变频率显著高于回族(P<0.05);c.235delC是GJB2基因的突变热点。结论青海省约有15.71%的非综合征型耳聋患者是由GJB2基因或mtDNA A155G突变所致。 Objective To reveal and analyze the characteristics of GJB2 and mitochondrial DNA A1555G mutations in patients with nonsyndromic sensorineural hearing loss in Qinghai Province. Methods 261 subjects in this study were collected from the schools for deafmutes and Outpatient Department in Qinghai province. Amplified the target fragments including GJB2 coding sequence, mtDNA12SrRNA. The amplicons of mtDNA12SrRNA were subjected to restriction enzyme Alw26I. The amplicons of patients whose enzyme reaction highly indicating A1555G mutation and amplicons of GJB2 were directly sequenced . Results The study revealed that 15.71% patients had two mutated alleles (homozygote and compound heterozygote) of GJB2 (9.58%) and mtDNA12SrRNA A1555G (6.13%). There were no significant difference in mtDNA A1555G mutation frequencies between the Han Chinese and Hui, but GJB2 mutation frequency in Han Chinese was significantly higher than in Hui. The c.235delC was still the mutational hot spot in GJB2. Conclusion About 15.71% of patients with nonsyndromic sensorineural hearing loss patients were caused by the mtDNA A1555G and GJB2 genes mutation in Qinghai province.
出处 《青海医学院学报》 CAS 2011年第4期217-221,共5页 Journal of Qinghai Medical College
关键词 耳聋 线粒体 DNA12SrRNA GJB2 流行病学 Deafness Mitochondrial DNA12SrRNA GJB2 Epidemiology
  • 相关文献

参考文献14

  • 1Marazita ML,Ploughman LM,Rawlings B,et al.Genetic epidemiological studies of early-onset deafness in the U.S.school-age population[J].Am J Med Genet,1993,46(5):486-491.
  • 2Meduri G U,Headley A S,Golden E,et al.Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome:a randomized controlled trial[J].JAMA,1998,280(2):159-165.
  • 3何中乾,蒋健,陆一鸣.纳洛酮在大鼠肠缺血再灌流致肺损伤中保护作用的初步研究[J].中国急救医学,2001,21(2):69-70. 被引量:12
  • 4Iwamura H,Inushima K,Taheuchi K,et al.Prophylactic effect of JTE-607 on LPS-induced acute lung injury in rats with CINC-1 inhibition [J].Inflamm Res,2002,51:160-166.
  • 5Cooke K R,Hill G R,Gerbitz A,et al.Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation[J].Transplantation,2000,70(2):272-279.
  • 6Yokoi K,Mukaida N,Harada A,et al.Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8[J].Lab Invest,1997,76(3):375-384.
  • 7Kuwabara K,Furue S,Tomita Y,et al.Effect of methylprednisolone on phospholipase A 2 activity and lung surfactant degradation in acute lung injury in rabbits[J].Eur J Pharmacol,2001,433(2-3):209-216.
  • 8Gutteberg T J,Osterud B,Volden G,et al.The production of tumour necrosis factor,tissue thromboplastin,lactoferrin and cathepsin C during lipopolysaccharide stimulation in whole blood[J].Scand J Clin Lab Invest,1990,50(4):421-427.
  • 9Marchant A,Amraoui Z,Gueydan C,et al.Methylprednisolone differentially regulates IL-10 and tumour necrosis factor (TNF)production during murine endotoxaemia[J].Clin Exp Immunol,1996,106(1):91-96.
  • 10Dziki A J,Lynch W H,Ramsey C B,et al.Beta-adrenergic-dependent and -independent actions of naloxone on perfusion during endotoxin shock[J].Circ Shock,1993,39(1):29-38.

二级参考文献9

  • 1Gurtis MT, Lefer AM. Protectiveactions of naloxone in hemorrhagic shock[J]. Am J Physiol, 1980,239(Heart CircPhysiol 8):H416-H421.
  • 2Dumont AE. Interstitial albumin-bound dye concentrations in mice with aprotein-rich effusion[J].Proc Soc Exp Biol Med, 1990, 194:221-223.
  • 3Turnage RH, Kadesky KM, Bartula L, et al. Intestinal reperfusion up-regulatesinducible nitric oxide synthase activity within the lung[J].Surgery, 1995,118:288-293.
  • 4Haglind E. Effects of continuous naloxone infusion in intestinal ischemia shock inthe rat[J].Circulatory Shock, 1992, 38:195-201.
  • 5Schmeling DJ, Caty MG, Oldham KT, et al. Evidence for neutrophil-related acute lunginjury after intestinal ischemia-reperfusion[J].Surgery, 1989, 106:195-202.
  • 6Caty MG, Guice KS, Oldham KT, et al. Evidence for tumor necrosis factor-inducedpulmonary microvascular injury after intestinal ischemia-reperfusion injury[J].AnnSurg, 1990,212(6):694-700.
  • 7Koike K, Moore EE, Moore FA, et al. Gut phospholipase A2 medialtes neutrophilpriming and lung injury after mesenteric ischemia-reperfusion[J].Am J Physiol, 1995,268(Gatrointest liver physiol 31):G397-G403.
  • 8Simpson R, Alon R, Kobzik L, et al. Neutrophil and nonneutrophil-mediated injury inintestinal ischemia-reperfustion[J].Ann Surg, 1993, 218(4):444-454.
  • 9Simpkins CO, Ives N, Tate E, et al. Naloxone inhibits superoxide release from humanneutrophils[J].Life Sciences, 1985, 37:1381-1386.

共引文献11

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部